{
    "medicine_id": "4f3e6b877c56b782498942be4f2a80fcc6ca5f4d",
    "platform_id": "DB06318",
    "metadata": {
        "name": "Elotuzumab 300 mg 1 Injection powder lyophilized for solution",
        "composition": "300 mg 1 AVE9633",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in leukemia myeloid",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "An immunoconjugate consisting of the humanized monoclonal antibody huMy9 6 conjugated to the cytotoxic maytansinoid derivative DM4 with potential antineoplastic activity The monoclonal antibody portion of anti CD33 monoclonal antibody DM4 conjugate AVE9633 specifically binds to the cell surface antigen CD33 expressed on myeloid leukemia cells upon internalization the DM4 moiety is released binds tubulin and disrupts microtubule assembly disassembly dynamics resulting in the inhibition of cell division and cell growth in myeloid leukemia cells that express CD33 CD33 is expressed on normal non pluripotent hematopoietic stem cells as well as on myeloid leukemia cells National Cancer Institute Drug Dictionary",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB09039",
                        "description": "The metabolism of Eliglustat can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "The metabolism of Ibrutinib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00802",
                        "description": "The serum concentration of Alfentanil can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00490",
                        "description": "The metabolism of Buspirone can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "The metabolism of Carbamazepine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00604",
                        "description": "The serum concentration of Cisapride can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00280",
                        "description": "AVE9633 may increase the QTc prolonging activities of Disopyramide"
                    },
                    {
                        "drugbank-id": "DB01215",
                        "description": "The serum concentration of Estazolam can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00468",
                        "description": "The serum concentration of Quinine can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00908",
                        "description": "The serum concentration of Quinidine can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00912",
                        "description": "The serum concentration of Repaglinide can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "The metabolism of Sirolimus can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "The metabolism of Temsirolimus can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00342",
                        "description": "The serum concentration of Terfenadine can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "The serum concentration of Triazolam can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01166",
                        "description": "The metabolism of Cilostazol can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The metabolism of Colchicine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00813",
                        "description": "The metabolism of Fentanyl can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB04946",
                        "description": "The metabolism of Iloperidone can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01256",
                        "description": "The metabolism of Retapamulin can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB08895",
                        "description": "The metabolism of Tofacitinib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00862",
                        "description": "The metabolism of Vardenafil can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00402",
                        "description": "The metabolism of Eszopiclone can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01198",
                        "description": "The metabolism of Zopiclone can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The metabolism of Lovastatin can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00346",
                        "description": "The metabolism of Alfuzosin can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00404",
                        "description": "The metabolism of Alprazolam can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00682",
                        "description": "The serum concentration of Warfarin can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01418",
                        "description": "The serum concentration of Acenocoumarol can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB08496",
                        "description": "The serum concentration of R warfarin can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB08735",
                        "description": "The serum concentration of R S Warfarin alcohol can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB08736",
                        "description": "The serum concentration of S R Warfarin alcohol can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB14055",
                        "description": "The serum concentration of S Warfarin can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00683",
                        "description": "The serum concentration of Midazolam can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The serum concentration of Tacrolimus can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05521",
                        "description": "The serum concentration of Telaprevir can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00269",
                        "description": "Chlorotrianisene may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB00655",
                        "description": "Estrone may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB00890",
                        "description": "Dienestrol may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB04573",
                        "description": "Estriol may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB04575",
                        "description": "Quinestrol may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB07931",
                        "description": "Hexestrol may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB09070",
                        "description": "Tibolone may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB09369",
                        "description": "Polyestradiol phosphate may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB11478",
                        "description": "Zeranol may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB11674",
                        "description": "Equol may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB12487",
                        "description": "Promestriene may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB13143",
                        "description": "Methallenestril may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB13386",
                        "description": "Epimestrol may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB13418",
                        "description": "Moxestrol may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB15334",
                        "description": "Biochanin A may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB15335",
                        "description": "Formononetin may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB00255",
                        "description": "Diethylstilbestrol may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB00286",
                        "description": "Conjugated estrogens may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "Estradiol may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "Ethinylestradiol may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB01357",
                        "description": "Mestranol may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB04574",
                        "description": "Estrone sulfate may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB09317",
                        "description": "Synthetic Conjugated Estrogens A may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB09318",
                        "description": "Synthetic Conjugated Estrogens B may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB09381",
                        "description": "Esterified estrogens may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "Estradiol acetate may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB13953",
                        "description": "Estradiol benzoate may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "Estradiol cypionate may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "Estradiol valerate may increase the thrombogenic activities of AVE9633"
                    },
                    {
                        "drugbank-id": "DB09268",
                        "description": "The therapeutic efficacy of Picosulfuric acid can be decreased when used in combination with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05168",
                        "description": "The serum concentration of Vintafolide can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13374",
                        "description": "The serum concentration of Vincamine can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00511",
                        "description": "The serum concentration of Acetyldigitoxin can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01078",
                        "description": "The serum concentration of Deslanoside can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01092",
                        "description": "The serum concentration of Ouabain can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB12843",
                        "description": "The serum concentration of Oleandrin can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13240",
                        "description": "The serum concentration of Cymarin can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13307",
                        "description": "The serum concentration of Proscillaridin can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "The serum concentration of Metildigoxin can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13467",
                        "description": "The serum concentration of Lanatoside C can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13537",
                        "description": "The serum concentration of Gitoformate can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "The serum concentration of Acetyldigoxin can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13756",
                        "description": "The serum concentration of Peruvoside can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The metabolism of Cyclosporine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00266",
                        "description": "The serum concentration of Dicoumarol can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00498",
                        "description": "The serum concentration of Phenindione can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB04665",
                        "description": "The serum concentration of Coumarin can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13451",
                        "description": "The serum concentration of Tioclomarol can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB08794",
                        "description": "The serum concentration of Ethyl biscoumacetate can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13347",
                        "description": "The serum concentration of Diphenadione can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB03410",
                        "description": "The serum concentration of 4 hydroxycoumarin can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13136",
                        "description": "The serum concentration of Fluindione can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13275",
                        "description": "The serum concentration of Clorindione can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01303",
                        "description": "The metabolism of Oxtriphylline can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB09273",
                        "description": "The metabolism of Doxofylline can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13203",
                        "description": "The metabolism of Bamifylline can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13573",
                        "description": "The metabolism of Acefylline can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13812",
                        "description": "The metabolism of Bufylline can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01482",
                        "description": "The metabolism of Fenethylline can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13449",
                        "description": "The metabolism of Proxyphylline can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB14018",
                        "description": "The metabolism of Bromotheophylline can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00806",
                        "description": "The metabolism of Pentoxifylline can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01667",
                        "description": "The metabolism of 8 azaguanine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01978",
                        "description": "The metabolism of 7 9 Dimethylguanine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB02134",
                        "description": "The metabolism of Xanthine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB02245",
                        "description": "The metabolism of 7 Deazaguanine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB02377",
                        "description": "The metabolism of Guanine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB02489",
                        "description": "The metabolism of 9 Methylguanine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB02568",
                        "description": "The metabolism of Peldesine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB04076",
                        "description": "The metabolism of Hypoxanthine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB04356",
                        "description": "The metabolism of 9 Deazaguanine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06575",
                        "description": "The metabolism of Valomaciclovir can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB07954",
                        "description": "The metabolism of 3 isobutyl 1 methyl 7H xanthine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB08844",
                        "description": "The metabolism of Uric acid can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB11919",
                        "description": "The metabolism of 6 O benzylguanine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB12406",
                        "description": "The metabolism of Lisofylline can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB12531",
                        "description": "The metabolism of Lobucavir can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB12926",
                        "description": "The metabolism of Cafedrine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB12927",
                        "description": "The metabolism of Theodrenaline can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13592",
                        "description": "The metabolism of Etamiphylline can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13634",
                        "description": "The metabolism of Pentifylline can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB14029",
                        "description": "The metabolism of Furafylline can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01412",
                        "description": "The metabolism of Theobromine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06479",
                        "description": "The metabolism of Propentofylline can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00201",
                        "description": "The metabolism of Caffeine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB14132",
                        "description": "The metabolism of 8 chlorotheophylline can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01033",
                        "description": "The metabolism of Mercaptopurine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB15122",
                        "description": "The metabolism of PCS 499 can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00353",
                        "description": "The serum concentration of Methylergometrine can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00589",
                        "description": "The serum concentration of Lisuride can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00699",
                        "description": "The serum concentration of Nicergoline can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01049",
                        "description": "The serum concentration of Ergoloid mesylate can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01186",
                        "description": "The serum concentration of Pergolide can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01253",
                        "description": "The serum concentration of Ergometrine can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB04829",
                        "description": "The serum concentration of Lysergic acid diethylamide can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB11273",
                        "description": "The serum concentration of Dihydroergocornine can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13345",
                        "description": "The serum concentration of Dihydroergocristine can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13385",
                        "description": "The serum concentration of Dihydroergocryptine can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13399",
                        "description": "The serum concentration of Terguride can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13520",
                        "description": "The serum concentration of Metergoline can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00247",
                        "description": "The serum concentration of Methysergide can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01200",
                        "description": "The serum concentration of Bromocriptine can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB12768",
                        "description": "The therapeutic efficacy of BCG vaccine can be decreased when used in combination with AVE9633"
                    },
                    {
                        "drugbank-id": "DB14022",
                        "description": "The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01076",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Atorvastatin"
                    },
                    {
                        "drugbank-id": "DB00002",
                        "description": "The risk or severity of adverse effects can be increased when Cetuximab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00028",
                        "description": "The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00043",
                        "description": "The risk or severity of adverse effects can be increased when Omalizumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "The risk or severity of adverse effects can be increased when Adalimumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00054",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00056",
                        "description": "The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00057",
                        "description": "The risk or severity of adverse effects can be increased when Indium In 111 satumomab pendetide is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The risk or severity of adverse effects can be increased when Infliximab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00072",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00073",
                        "description": "The risk or severity of adverse effects can be increased when Rituximab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00074",
                        "description": "The risk or severity of adverse effects can be increased when Basiliximab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00075",
                        "description": "The risk or severity of adverse effects can be increased when Muromonab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00076",
                        "description": "The risk or severity of adverse effects can be increased when Digoxin Immune Fab Ovine is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00078",
                        "description": "The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00081",
                        "description": "The risk or severity of adverse effects can be increased when Tositumomab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00087",
                        "description": "The risk or severity of adverse effects can be increased when Alemtuzumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00089",
                        "description": "The risk or severity of adverse effects can be increased when Capromab pendetide is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00095",
                        "description": "The risk or severity of adverse effects can be increased when Efalizumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00098",
                        "description": "The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin rabbit is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00108",
                        "description": "The risk or severity of adverse effects can be increased when Natalizumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00110",
                        "description": "The risk or severity of adverse effects can be increased when Palivizumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00111",
                        "description": "The risk or severity of adverse effects can be increased when Daclizumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00112",
                        "description": "The risk or severity of adverse effects can be increased when Bevacizumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00113",
                        "description": "The risk or severity of adverse effects can be increased when Technetium Tc 99m arcitumomab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01257",
                        "description": "The risk or severity of adverse effects can be increased when Eculizumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01269",
                        "description": "The risk or severity of adverse effects can be increased when Panitumumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01270",
                        "description": "The risk or severity of adverse effects can be increased when Ranibizumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB04901",
                        "description": "The risk or severity of adverse effects can be increased when Galiximab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB04949",
                        "description": "The risk or severity of adverse effects can be increased when Pexelizumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "The risk or severity of adverse effects can be increased when Afelimomab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB04958",
                        "description": "The risk or severity of adverse effects can be increased when Epratuzumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB04962",
                        "description": "The risk or severity of adverse effects can be increased when Bectumomab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB04964",
                        "description": "The risk or severity of adverse effects can be increased when Oregovomab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB04988",
                        "description": "The risk or severity of adverse effects can be increased when IGN311 is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05006",
                        "description": "The risk or severity of adverse effects can be increased when Adecatumumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05097",
                        "description": "The risk or severity of adverse effects can be increased when Labetuzumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05101",
                        "description": "The risk or severity of adverse effects can be increased when Matuzumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05111",
                        "description": "The risk or severity of adverse effects can be increased when Fontolizumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05136",
                        "description": "The risk or severity of adverse effects can be increased when Bavituximab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05139",
                        "description": "The risk or severity of adverse effects can be increased when CR002 is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05209",
                        "description": "The risk or severity of adverse effects can be increased when Rozrolimupab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05304",
                        "description": "The risk or severity of adverse effects can be increased when Girentuximab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05336",
                        "description": "The risk or severity of adverse effects can be increased when Obiltoxaximab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05405",
                        "description": "The risk or severity of adverse effects can be increased when XTL 001 is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05437",
                        "description": "The risk or severity of adverse effects can be increased when NAV 1800 is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05459",
                        "description": "The risk or severity of adverse effects can be increased when Briakinumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05496",
                        "description": "The risk or severity of adverse effects can be increased when Otelixizumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05545",
                        "description": "The risk or severity of adverse effects can be increased when AMG 108 is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05550",
                        "description": "The risk or severity of adverse effects can be increased when Iratumumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05555",
                        "description": "The risk or severity of adverse effects can be increased when Enokizumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05578",
                        "description": "The risk or severity of adverse effects can be increased when Ramucirumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05595",
                        "description": "The risk or severity of adverse effects can be increased when Farletuzumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05656",
                        "description": "The risk or severity of adverse effects can be increased when Veltuzumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05679",
                        "description": "The risk or severity of adverse effects can be increased when Ustekinumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05793",
                        "description": "The risk or severity of adverse effects can be increased when PRO 542 is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05797",
                        "description": "The risk or severity of adverse effects can be increased when TNX 901 is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05889",
                        "description": "The risk or severity of adverse effects can be increased when Inotuzumab ozogamicin is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05892",
                        "description": "The risk or severity of adverse effects can be increased when RI 624 is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05915",
                        "description": "The risk or severity of adverse effects can be increased when MYO 029 is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05916",
                        "description": "The risk or severity of adverse effects can be increased when CT 011 is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05941",
                        "description": "The risk or severity of adverse effects can be increased when Leronlimab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05996",
                        "description": "The risk or severity of adverse effects can be increased when Glembatumumab vedotin is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06043",
                        "description": "The risk or severity of adverse effects can be increased when Olaratumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06049",
                        "description": "The risk or severity of adverse effects can be increased when IPH 2101 is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06050",
                        "description": "The risk or severity of adverse effects can be increased when TB 402 is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06081",
                        "description": "The risk or severity of adverse effects can be increased when Caplacizumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06101",
                        "description": "The risk or severity of adverse effects can be increased when IMC 1C11 is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06116",
                        "description": "The risk or severity of adverse effects can be increased when Eldelumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06162",
                        "description": "The risk or severity of adverse effects can be increased when Lumiliximab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "The risk or severity of adverse effects can be increased when Canakinumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06186",
                        "description": "The risk or severity of adverse effects can be increased when Ipilimumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06192",
                        "description": "The risk or severity of adverse effects can be increased when Nimotuzumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06241",
                        "description": "The risk or severity of adverse effects can be increased when Clenoliximab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "The risk or severity of adverse effects can be increased when Tocilizumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06304",
                        "description": "The risk or severity of adverse effects can be increased when BIIB015 is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06305",
                        "description": "The risk or severity of adverse effects can be increased when Sonepcizumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06310",
                        "description": "The risk or severity of adverse effects can be increased when Motavizumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06317",
                        "description": "The risk or severity of adverse effects can be increased when Elotuzumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06322",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Carotuximab"
                    },
                    {
                        "drugbank-id": "DB06324",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with XmAb 2513"
                    },
                    {
                        "drugbank-id": "DB06342",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Coltuximab ravtansine"
                    },
                    {
                        "drugbank-id": "DB06343",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Teprotumumab"
                    },
                    {
                        "drugbank-id": "DB06360",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Lucatumumab"
                    },
                    {
                        "drugbank-id": "DB06366",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Pertuzumab"
                    },
                    {
                        "drugbank-id": "DB06371",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Siplizumab"
                    },
                    {
                        "drugbank-id": "DB06467",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Apolizumab"
                    },
                    {
                        "drugbank-id": "DB06474",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Sibrotuzumab"
                    },
                    {
                        "drugbank-id": "DB06550",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Bivatuzumab"
                    },
                    {
                        "drugbank-id": "DB06557",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Lerdelimumab"
                    },
                    {
                        "drugbank-id": "DB06599",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Lexatumumab"
                    },
                    {
                        "drugbank-id": "DB06602",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Reslizumab"
                    },
                    {
                        "drugbank-id": "DB06606",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Teplizumab"
                    },
                    {
                        "drugbank-id": "DB06607",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Catumaxomab"
                    },
                    {
                        "drugbank-id": "DB06612",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Mepolizumab"
                    },
                    {
                        "drugbank-id": "DB06643",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Denosumab"
                    },
                    {
                        "drugbank-id": "DB06647",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Volociximab"
                    },
                    {
                        "drugbank-id": "DB06650",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Ofatumumab"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Golimumab"
                    },
                    {
                        "drugbank-id": "DB08879",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Belimumab"
                    },
                    {
                        "drugbank-id": "DB08902",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Raxibacumab"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB08935",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Obinutuzumab"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Secukinumab"
                    },
                    {
                        "drugbank-id": "DB09033",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Vedolizumab"
                    },
                    {
                        "drugbank-id": "DB09035",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Nivolumab"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Siltuximab"
                    },
                    {
                        "drugbank-id": "DB09037",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Pembrolizumab"
                    },
                    {
                        "drugbank-id": "DB09045",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Dulaglutide"
                    },
                    {
                        "drugbank-id": "DB09052",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Blinatumomab"
                    },
                    {
                        "drugbank-id": "DB09077",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Dinutuximab"
                    },
                    {
                        "drugbank-id": "DB09105",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Asfotase alfa"
                    },
                    {
                        "drugbank-id": "DB09264",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Idarucizumab"
                    },
                    {
                        "drugbank-id": "DB09302",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Alirocumab"
                    },
                    {
                        "drugbank-id": "DB09303",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Evolocumab"
                    },
                    {
                        "drugbank-id": "DB09312",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Antilymphocyte immunoglobulin horse"
                    },
                    {
                        "drugbank-id": "DB09331",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Daratumumab"
                    },
                    {
                        "drugbank-id": "DB09559",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Necitumumab"
                    },
                    {
                        "drugbank-id": "DB11569",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Ixekizumab"
                    },
                    {
                        "drugbank-id": "DB11580",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Ravulizumab"
                    },
                    {
                        "drugbank-id": "DB11595",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Atezolizumab"
                    },
                    {
                        "drugbank-id": "DB11604",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Tetanus Immune Globulin"
                    },
                    {
                        "drugbank-id": "DB11608",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Eftrenonacog alfa"
                    },
                    {
                        "drugbank-id": "DB11621",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Human Varicella Zoster Immune Globulin"
                    },
                    {
                        "drugbank-id": "DB11646",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Conatumumab"
                    },
                    {
                        "drugbank-id": "DB11657",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Tabalumab"
                    },
                    {
                        "drugbank-id": "DB11680",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Ficlatuzumab"
                    },
                    {
                        "drugbank-id": "DB11685",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Figitumumab"
                    },
                    {
                        "drugbank-id": "DB11714",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Durvalumab"
                    },
                    {
                        "drugbank-id": "DB11715",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Bapineuzumab"
                    },
                    {
                        "drugbank-id": "DB11731",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Depatuxizumab mafodotin"
                    },
                    {
                        "drugbank-id": "DB11746",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Onartuzumab"
                    },
                    {
                        "drugbank-id": "DB11756",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Solanezumab"
                    },
                    {
                        "drugbank-id": "DB11767",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Sarilumab"
                    },
                    {
                        "drugbank-id": "DB11771",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Tremelimumab"
                    },
                    {
                        "drugbank-id": "DB11776",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Brodalumab"
                    },
                    {
                        "drugbank-id": "DB11803",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Sirukumab"
                    },
                    {
                        "drugbank-id": "DB11826",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Lampalizumab"
                    },
                    {
                        "drugbank-id": "DB11834",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Guselkumab"
                    },
                    {
                        "drugbank-id": "DB11840",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Dalotuzumab"
                    },
                    {
                        "drugbank-id": "DB11849",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Emibetuzumab"
                    },
                    {
                        "drugbank-id": "DB11850",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Ublituximab"
                    },
                    {
                        "drugbank-id": "DB11856",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Ligelizumab"
                    },
                    {
                        "drugbank-id": "DB11857",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Seribantumab"
                    },
                    {
                        "drugbank-id": "DB11862",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Landogrozumab"
                    },
                    {
                        "drugbank-id": "DB11866",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Romosozumab"
                    },
                    {
                        "drugbank-id": "DB11884",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Vadastuximab Talirine"
                    },
                    {
                        "drugbank-id": "DB11914",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Lebrikizumab"
                    },
                    {
                        "drugbank-id": "DB11930",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Varlilumab"
                    },
                    {
                        "drugbank-id": "DB11945",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Avelumab"
                    },
                    {
                        "drugbank-id": "DB11959",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Crenezumab"
                    },
                    {
                        "drugbank-id": "DB11972",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Rilotumumab"
                    },
                    {
                        "drugbank-id": "DB11976",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Anifrolumab"
                    },
                    {
                        "drugbank-id": "DB11988",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Ocrelizumab"
                    },
                    {
                        "drugbank-id": "DB12023",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Benralizumab"
                    },
                    {
                        "drugbank-id": "DB12034",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Gantenerumab"
                    },
                    {
                        "drugbank-id": "DB12053",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Visilizumab"
                    },
                    {
                        "drugbank-id": "DB12077",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Urelumab"
                    },
                    {
                        "drugbank-id": "DB12089",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Lorvotuzumab mertansine"
                    },
                    {
                        "drugbank-id": "DB12090",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Patritumab"
                    },
                    {
                        "drugbank-id": "DB12102",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Fulranumab"
                    },
                    {
                        "drugbank-id": "DB12104",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Tarextumab"
                    },
                    {
                        "drugbank-id": "DB12118",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Sotatercept"
                    },
                    {
                        "drugbank-id": "DB12119",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Gevokizumab"
                    },
                    {
                        "drugbank-id": "DB12142",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Duligotuzumab"
                    },
                    {
                        "drugbank-id": "DB12152",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Simtuzumab"
                    },
                    {
                        "drugbank-id": "DB12157",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Fasinumab"
                    },
                    {
                        "drugbank-id": "DB12159",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Dupilumab"
                    },
                    {
                        "drugbank-id": "DB12169",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Tralokinumab"
                    },
                    {
                        "drugbank-id": "DB12189",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Etrolizumab"
                    },
                    {
                        "drugbank-id": "DB12202",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Zalutumumab"
                    },
                    {
                        "drugbank-id": "DB12205",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Ganitumab"
                    },
                    {
                        "drugbank-id": "DB12213",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Etaracizumab"
                    },
                    {
                        "drugbank-id": "DB12246",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Inclacumab"
                    },
                    {
                        "drugbank-id": "DB12250",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Cixutumumab"
                    },
                    {
                        "drugbank-id": "DB12261",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Ascrinvacumab"
                    },
                    {
                        "drugbank-id": "DB12274",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Aducanumab"
                    },
                    {
                        "drugbank-id": "DB12281",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Luspatercept"
                    },
                    {
                        "drugbank-id": "DB12296",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with GS 5745"
                    },
                    {
                        "drugbank-id": "DB12317",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Vanucizumab"
                    },
                    {
                        "drugbank-id": "DB12331",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Labetuzumab govitecan"
                    },
                    {
                        "drugbank-id": "DB12335",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Tanezumab"
                    },
                    {
                        "drugbank-id": "DB12342",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Ensituximab"
                    },
                    {
                        "drugbank-id": "DB12344",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Fezakinumab"
                    },
                    {
                        "drugbank-id": "DB12363",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Dusigitumab"
                    },
                    {
                        "drugbank-id": "DB12396",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Fresolimumab"
                    },
                    {
                        "drugbank-id": "DB12413",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Indusatumab vedotin"
                    },
                    {
                        "drugbank-id": "DB12456",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Bococizumab"
                    },
                    {
                        "drugbank-id": "DB12489",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Mirvetuximab Soravtansine"
                    },
                    {
                        "drugbank-id": "DB12498",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Mogamulizumab"
                    },
                    {
                        "drugbank-id": "DB12520",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Plozalizumab"
                    },
                    {
                        "drugbank-id": "DB12530",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Inebilizumab"
                    },
                    {
                        "drugbank-id": "DB12534",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Mavrilimumab"
                    },
                    {
                        "drugbank-id": "DB12560",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Blosozumab"
                    },
                    {
                        "drugbank-id": "DB12584",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Bimagrumab"
                    },
                    {
                        "drugbank-id": "DB12589",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Dacetuzumab"
                    },
                    {
                        "drugbank-id": "DB12609",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Tovetumab"
                    },
                    {
                        "drugbank-id": "DB12683",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Lumretuzumab"
                    },
                    {
                        "drugbank-id": "DB12698",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Ibalizumab"
                    },
                    {
                        "drugbank-id": "DB12701",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Intetumumab"
                    },
                    {
                        "drugbank-id": "DB12718",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Carlumab"
                    },
                    {
                        "drugbank-id": "DB12734",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Demcizumab"
                    },
                    {
                        "drugbank-id": "DB12773",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Sifalimumab"
                    },
                    {
                        "drugbank-id": "DB12775",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Abituzumab"
                    },
                    {
                        "drugbank-id": "DB12797",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Ecromeximab"
                    },
                    {
                        "drugbank-id": "DB12807",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Naptumomab Estafenatox"
                    },
                    {
                        "drugbank-id": "DB12815",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Crotedumab"
                    },
                    {
                        "drugbank-id": "DB12820",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Concizumab"
                    },
                    {
                        "drugbank-id": "DB12826",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Depatuxizumab"
                    },
                    {
                        "drugbank-id": "DB12844",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Rontalizumab"
                    },
                    {
                        "drugbank-id": "DB12845",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Amatuximab"
                    },
                    {
                        "drugbank-id": "DB12849",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Clazakizumab"
                    },
                    {
                        "drugbank-id": "DB12891",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Ozanezumab"
                    },
                    {
                        "drugbank-id": "DB12893",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Sacituzumab govitecan"
                    },
                    {
                        "drugbank-id": "DB12917",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Bimekizumab"
                    },
                    {
                        "drugbank-id": "DB12943",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Milatuzumab"
                    },
                    {
                        "drugbank-id": "DB12976",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Robatumumab"
                    },
                    {
                        "drugbank-id": "DB13017",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Rovalpituzumab Tesirine"
                    },
                    {
                        "drugbank-id": "DB13037",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Namilumab"
                    },
                    {
                        "drugbank-id": "DB13045",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Racotumomab"
                    },
                    {
                        "drugbank-id": "DB13073",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Tregalizumab"
                    },
                    {
                        "drugbank-id": "DB13127",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Olokizumab"
                    },
                    {
                        "drugbank-id": "DB13140",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Bezlotoxumab"
                    },
                    {
                        "drugbank-id": "DB13375",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Edrecolomab"
                    },
                    {
                        "drugbank-id": "DB13535",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Nebacumab"
                    },
                    {
                        "drugbank-id": "DB13886",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Human cytomegalovirus immune globulin"
                    },
                    {
                        "drugbank-id": "DB13923",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Emicizumab"
                    },
                    {
                        "drugbank-id": "DB13976",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Sulesomab"
                    },
                    {
                        "drugbank-id": "DB13979",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Besilesomab"
                    },
                    {
                        "drugbank-id": "DB14004",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Tildrakizumab"
                    },
                    {
                        "drugbank-id": "DB14012",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Burosumab"
                    },
                    {
                        "drugbank-id": "DB14039",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Erenumab"
                    },
                    {
                        "drugbank-id": "DB14040",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Eptinezumab"
                    },
                    {
                        "drugbank-id": "DB14041",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Fremanezumab"
                    },
                    {
                        "drugbank-id": "DB14042",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Galcanezumab"
                    },
                    {
                        "drugbank-id": "DB14211",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Fanolesomab"
                    },
                    {
                        "drugbank-id": "DB14580",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Lecanemab"
                    },
                    {
                        "drugbank-id": "DB14597",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Lanadelumab"
                    },
                    {
                        "drugbank-id": "DB14707",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Cemiplimab"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Emapalumab"
                    },
                    {
                        "drugbank-id": "DB14762",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Risankizumab"
                    },
                    {
                        "drugbank-id": "DB14776",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Camrelizumab"
                    },
                    {
                        "drugbank-id": "DB14778",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Setrusumab"
                    },
                    {
                        "drugbank-id": "DB14784",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Gancotamab"
                    },
                    {
                        "drugbank-id": "DB14809",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Anetumab ravtansine"
                    },
                    {
                        "drugbank-id": "DB14811",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Isatuximab"
                    },
                    {
                        "drugbank-id": "DB14824",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Icrucumab"
                    },
                    {
                        "drugbank-id": "DB14843",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Codrituzumab"
                    },
                    {
                        "drugbank-id": "DB14864",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Brolucizumab"
                    },
                    {
                        "drugbank-id": "DB14871",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Xentuzumab"
                    },
                    {
                        "drugbank-id": "DB14877",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Lintuzumab"
                    },
                    {
                        "drugbank-id": "DB14891",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Vobarilizumab"
                    },
                    {
                        "drugbank-id": "DB14897",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Parsatuzumab"
                    },
                    {
                        "drugbank-id": "DB14905",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Emactuzumab"
                    },
                    {
                        "drugbank-id": "DB14907",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Bevacizumab zirconium Zr 89"
                    },
                    {
                        "drugbank-id": "DB14908",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Refanezumab"
                    },
                    {
                        "drugbank-id": "DB14919",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Rozanolixizumab"
                    },
                    {
                        "drugbank-id": "DB14947",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Bermekimab"
                    },
                    {
                        "drugbank-id": "DB14952",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Pamrevlumab"
                    },
                    {
                        "drugbank-id": "DB14959",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Opicinumab"
                    },
                    {
                        "drugbank-id": "DB14962",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Trastuzumab deruxtecan"
                    },
                    {
                        "drugbank-id": "DB14967",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Margetuximab"
                    },
                    {
                        "drugbank-id": "DB14988",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Dalantercept"
                    },
                    {
                        "drugbank-id": "DB14997",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Pateclizumab"
                    },
                    {
                        "drugbank-id": "DB15014",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Gremubamab"
                    },
                    {
                        "drugbank-id": "DB15022",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Apomab"
                    },
                    {
                        "drugbank-id": "DB15044",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Tafasitamab"
                    },
                    {
                        "drugbank-id": "DB15045",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Ipafricept"
                    },
                    {
                        "drugbank-id": "DB15076",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Abrilumab"
                    },
                    {
                        "drugbank-id": "DB15089",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Frovocimab"
                    },
                    {
                        "drugbank-id": "DB15090",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Tezepelumab"
                    },
                    {
                        "drugbank-id": "DB15101",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Tigatuzumab"
                    },
                    {
                        "drugbank-id": "DB15104",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Telisotuzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB15113",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Utomilumab"
                    },
                    {
                        "drugbank-id": "DB15118",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Zolbetuximab"
                    },
                    {
                        "drugbank-id": "DB15135",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Ponezumab"
                    },
                    {
                        "drugbank-id": "DB15160",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Asunercept"
                    },
                    {
                        "drugbank-id": "DB15172",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Suvratoxumab"
                    },
                    {
                        "drugbank-id": "DB15225",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Mitazalimab"
                    },
                    {
                        "drugbank-id": "DB15252",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Nemolizumab"
                    },
                    {
                        "drugbank-id": "DB15253",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Bleselumab"
                    },
                    {
                        "drugbank-id": "DB15277",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Gedivumab"
                    },
                    {
                        "drugbank-id": "DB15336",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Valanafusp alfa"
                    },
                    {
                        "drugbank-id": "DB15349",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Sofituzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB15354",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Evinacumab"
                    },
                    {
                        "drugbank-id": "DB15363",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Istiratumab"
                    },
                    {
                        "drugbank-id": "DB15383",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Pidilizumab"
                    },
                    {
                        "drugbank-id": "DB15397",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with GMA 161"
                    },
                    {
                        "drugbank-id": "DB15409",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Ladiratuzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB15415",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Tomaralimab"
                    },
                    {
                        "drugbank-id": "DB15428",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Vesencumab"
                    },
                    {
                        "drugbank-id": "DB15432",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Pinatuzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB15441",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Lulizumab pegol"
                    },
                    {
                        "drugbank-id": "DB15443",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Lorukafusp alfa"
                    },
                    {
                        "drugbank-id": "DB15453",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Naratuximab emtansine"
                    },
                    {
                        "drugbank-id": "DB09057",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Anthrax immune globulin human"
                    },
                    {
                        "drugbank-id": "DB12240",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Polatuzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB15559",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Zenocutuzumab"
                    },
                    {
                        "drugbank-id": "DB15898",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Atoltivimab"
                    },
                    {
                        "drugbank-id": "DB15899",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Maftivimab"
                    },
                    {
                        "drugbank-id": "DB15900",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Odesivimab"
                    },
                    {
                        "drugbank-id": "DB15719",
                        "description": "The risk or severity of adverse effects can be increased when AVE9633 is combined with Belantamab mafodotin"
                    },
                    {
                        "drugbank-id": "DB01238",
                        "description": "The metabolism of Aripiprazole can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB14185",
                        "description": "The metabolism of Aripiprazole lauroxil can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00186",
                        "description": "The metabolism of Lorazepam can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00191",
                        "description": "The metabolism of Phentermine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00207",
                        "description": "The metabolism of Azithromycin can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00208",
                        "description": "The metabolism of Ticlopidine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00246",
                        "description": "The metabolism of Ziprasidone can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00264",
                        "description": "The metabolism of Metoprolol can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00426",
                        "description": "The metabolism of Famciclovir can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00433",
                        "description": "The metabolism of Prochlorperazine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00476",
                        "description": "The metabolism of Duloxetine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00477",
                        "description": "The metabolism of Chlorpromazine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00518",
                        "description": "The metabolism of Albendazole can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00567",
                        "description": "The metabolism of Cephalexin can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00590",
                        "description": "The metabolism of Doxazosin can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00717",
                        "description": "The metabolism of Norethisterone can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "The metabolism of Fenofibrate can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01072",
                        "description": "The metabolism of Atazanavir can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "The metabolism of Rosuvastatin can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01323",
                        "description": "The metabolism of St John s Wort can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "The metabolism of Drospirenone can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01411",
                        "description": "The metabolism of Pranlukast can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01431",
                        "description": "The metabolism of Allylestrenol can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01624",
                        "description": "The metabolism of Zuclopenthixol can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01656",
                        "description": "The metabolism of Roflumilast can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06201",
                        "description": "The metabolism of Rufinamide can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06218",
                        "description": "The metabolism of Lacosamide can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB08882",
                        "description": "The metabolism of Linagliptin can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB09030",
                        "description": "The metabolism of Vorapaxar can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB09034",
                        "description": "The metabolism of Suvorexant can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB09048",
                        "description": "The metabolism of Netupitant can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB09071",
                        "description": "The metabolism of Tasimelteon can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB09079",
                        "description": "The metabolism of Nintedanib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB09299",
                        "description": "The metabolism of Tenofovir alafenamide can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB11094",
                        "description": "The metabolism of Vitamin D can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB11730",
                        "description": "The metabolism of Ribociclib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB11952",
                        "description": "The metabolism of Duvelisib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB12141",
                        "description": "The metabolism of Gilteritinib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB12515",
                        "description": "The metabolism of 9 aminocamptothecin can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB12952",
                        "description": "The metabolism of Methylprednisone can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB14009",
                        "description": "The metabolism of Medical Cannabis can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB14126",
                        "description": "The metabolism of Tenofovir can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00549",
                        "description": "The metabolism of Zafirlukast can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB15444",
                        "description": "The metabolism of Elexacaftor can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB12887",
                        "description": "The metabolism of Tazemetostat can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06717",
                        "description": "The metabolism of Fosaprepitant can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB12825",
                        "description": "The metabolism of Lefamulin can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00454",
                        "description": "The metabolism of Meperidine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB11742",
                        "description": "The metabolism of Ebastine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB11633",
                        "description": "The metabolism of Isavuconazole can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00309",
                        "description": "The metabolism of Vindesine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "The metabolism of Vinorelbine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The metabolism of Vincristine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "The metabolism of Vinblastine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB11641",
                        "description": "The metabolism of Vinflunine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00248",
                        "description": "The metabolism of Cabergoline can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00204",
                        "description": "The metabolism of Dofetilide can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00277",
                        "description": "The metabolism of Theophylline can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00946",
                        "description": "The metabolism of Phenprocoumon can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01008",
                        "description": "The metabolism of Busulfan can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01100",
                        "description": "The metabolism of Pimozide can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The metabolism of Amiodarone can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01223",
                        "description": "The metabolism of Aminophylline can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The metabolism of Paclitaxel can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "The metabolism of Dasatinib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01320",
                        "description": "The metabolism of Fosphenytoin can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "The metabolism of Digitoxin can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "The metabolism of Everolimus can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB04855",
                        "description": "The metabolism of Dronedarone can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05239",
                        "description": "The metabolism of Cobimetinib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB09054",
                        "description": "The metabolism of Idelalisib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB09063",
                        "description": "The metabolism of Ceritinib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The metabolism of Tianeptine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB09330",
                        "description": "The metabolism of Osimertinib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB11963",
                        "description": "The metabolism of Dacomitinib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB12015",
                        "description": "The metabolism of Alpelisib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "The metabolism of AVE9633 can be decreased when combined with Trastuzumab emtansine"
                    },
                    {
                        "drugbank-id": "DB08870",
                        "description": "The metabolism of Brentuximab vedotin can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00320",
                        "description": "The metabolism of Dihydroergotamine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00696",
                        "description": "The metabolism of Ergotamine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00637",
                        "description": "The metabolism of Astemizole can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB08827",
                        "description": "The metabolism of Lomitapide can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB12371",
                        "description": "The metabolism of Siponimod can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The metabolism of Methotrexate can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The metabolism of Doxorubicin can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The metabolism of Docetaxel can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "The metabolism of Thiotepa can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The metabolism of Trabectedin can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB05294",
                        "description": "The metabolism of Vandetanib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB08881",
                        "description": "The metabolism of Vemurafenib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB11363",
                        "description": "The metabolism of Alectinib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB11581",
                        "description": "The metabolism of Venetoclax can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB11703",
                        "description": "The metabolism of Acalabrutinib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13874",
                        "description": "The metabolism of Enasidenib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB15035",
                        "description": "The metabolism of Zanubrutinib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "The metabolism of Bortezomib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "The metabolism of Sorafenib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "The metabolism of Teniposide can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00530",
                        "description": "The metabolism of Erlotinib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The metabolism of Tamoxifen can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "The metabolism of Etoposide can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "The metabolism of Ifosfamide can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "The metabolism of Sunitinib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB04845",
                        "description": "The metabolism of Ixabepilone can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "The metabolism of Nilotinib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "The metabolism of Pazopanib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06595",
                        "description": "The metabolism of Midostaurin can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "The metabolism of Panobinostat can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "The metabolism of Bosutinib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06626",
                        "description": "The metabolism of Axitinib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB08865",
                        "description": "The metabolism of Crizotinib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "The metabolism of Ruxolitinib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "The metabolism of Ponatinib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB08912",
                        "description": "The metabolism of Dabrafenib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "The metabolism of Palbociclib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB09143",
                        "description": "The metabolism of Sonidegib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB09570",
                        "description": "The metabolism of Ixazomib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB11828",
                        "description": "The metabolism of Neratinib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB12147",
                        "description": "The metabolism of Erdafitinib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB12267",
                        "description": "The metabolism of Brigatinib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB12483",
                        "description": "The metabolism of Copanlisib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB12978",
                        "description": "The metabolism of Pexidartinib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB14568",
                        "description": "The metabolism of Ivosidenib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00575",
                        "description": "The metabolism of Clonidine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "The metabolism of Irinotecan can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06176",
                        "description": "The metabolism of Romidepsin can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06212",
                        "description": "The metabolism of Tolvaptan can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB08896",
                        "description": "The metabolism of Regorafenib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "The metabolism of Pomalidomide can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "The metabolism of Olaparib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "The metabolism of Baricitinib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB12001",
                        "description": "The metabolism of Abemaciclib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "The metabolism of Cyclophosphamide can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00540",
                        "description": "The metabolism of Nortriptyline can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00872",
                        "description": "The metabolism of Conivaptan can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01128",
                        "description": "The metabolism of Bicalutamide can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01227",
                        "description": "The metabolism of Levacetylmethadol can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01242",
                        "description": "The metabolism of Clomipramine can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "The metabolism of Cabazitaxel can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06480",
                        "description": "The metabolism of Prucalopride can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "The serum concentration of Digoxin can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00581",
                        "description": "The therapeutic efficacy of Lactulose can be decreased when used in combination with AVE9633"
                    },
                    {
                        "drugbank-id": "DB11986",
                        "description": "The metabolism of Entrectinib can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "AVE9633 may decrease the excretion rate of Triamcinolone which could result in a higher serum level"
                    },
                    {
                        "drugbank-id": "DB14975",
                        "description": "The serum concentration of Voxelotor can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB09237",
                        "description": "The serum concentration of Levamlodipine can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB15595",
                        "description": "The therapeutic efficacy of Ebola Zaire vaccine live attenuated can be decreased when used in combination with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00193",
                        "description": "The metabolism of Tramadol can be decreased when combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00180",
                        "description": "The serum concentration of Flunisolide can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The serum concentration of Betamethasone can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "The serum concentration of Prednisone can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00687",
                        "description": "The serum concentration of Fludrocortisone can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "The serum concentration of Hydrocortisone can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00860",
                        "description": "The serum concentration of Prednisolone can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00959",
                        "description": "The serum concentration of Methylprednisolone can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01108",
                        "description": "The serum concentration of Trilostane can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "The serum concentration of Budesonide can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The serum concentration of Dexamethasone can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01285",
                        "description": "The serum concentration of Corticotropin can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "The serum concentration of Cortisone acetate can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "The serum concentration of Paramethasone can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB04630",
                        "description": "The serum concentration of Aldosterone can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB09378",
                        "description": "The serum concentration of Fluprednisolone can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "The serum concentration of Meprednisone can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB11529",
                        "description": "The serum concentration of Melengestrol can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "The serum concentration of Deflazacort can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "The serum concentration of Cortivazol can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "The serum concentration of Prednylidene can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "The serum concentration of Cloprednol can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB14681",
                        "description": "The serum concentration of Cortisone can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB00502",
                        "description": "The serum concentration of Haloperidol can be increased when it is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB14443",
                        "description": "The therapeutic efficacy of Vibrio cholerae CVD 103 HgR strain live antigen can be decreased when used in combination with AVE9633"
                    },
                    {
                        "drugbank-id": "DB15258",
                        "description": "The therapeutic efficacy of AVE9633 can be decreased when used in combination with Imlifidase"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}